" /> delta9-Tetrahydrocannabinol/Cannabidiol Combination Agent - CISMeF





Preferred Label : delta9-Tetrahydrocannabinol/Cannabidiol Combination Agent;

NCIt synonyms : d9-THC/CBD Nanoparticle-based Combination Agent;

NCIt definition : A sub-micron spray containing a nanoparticle water soluble equimolar solution composed of delta-9-tetrahydrocannabinol (delta-9-THC; d9-THC), an analogue of tetrahydrocannabinol (THC) and the primary form of THC found in the Cannabis sativa L. plant, and cannabidiol (CBD), a phytocannabinoid derived from Cannabis species, with potential analgesic activity. Upon administration to the oro-buccal membrane, d9-THC/CBD combination agent binds to and activates the cannabinoid G-protein coupled receptor (CBR) located in the central nervous system (CNS). This activates the inwardly rectifying potassium channels, which decrease presynaptic neuron firing, and inhibits voltage-sensitive calcium channels that decrease neurotransmitter release. This inhibits excitatory postsynaptic neuronal transmission, and inhibits the release of pro-inflammatory mediators. This provides an analgesic effect.;

Drug name : NanaBis;

Molecule name : MDCNB-01;

NCI Metathesaurus CUI : CL1662766;

Details


You can consult :


Nous contacter.
29/08/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.